L2M-Market Evaluation and Commercialization Strategy for APOBEC3-Targeted Therapies in Oncology

This project aims to assist a partner organization in evaluating the market potential of a novel APOBEC3 inhibitor as a cancer treatment. The focus will be on conducting comprehensive market research to understand the demand for this innovative therapy, explore its commercial viability, and identify potential partners in the biopharmaceutical industry. The project will assess the competitive landscape by analyzing existing therapies and identifying opportunities for differentiation, positioning the APOBEC3 inhibitor as a unique and valuable solution in oncology.
One key aspect of the project is identifying potential commercial partners, such as pharmaceutical companies, biotech firms, and investors, who may be interested in licensing or co-developing the APOBEC3 inhibitor. Additionally, the project will evaluate various business models, revenue generation opportunities, and market access strategies to ensure the therapy’s successful commercialization. This will include assessing the regulatory landscape, identifying key approval requirements, and mapping out pathways for efficient product approval.
The project will also explore the broader economic and healthcare impacts of the APOBEC3 inhibitor, including its potential to reduce healthcare costs and improve patient outcomes compared to existing cancer therapies. This research will contribute to a deeper understanding of how this therapy can meet unmet needs in cancer treatment.
Ultimately, the expected benefit to the partner organization is the creation of a clear and actionable strategy for bringing the APOBEC3 inhibitor to market. This will include identifying key stakeholders, building relationships with potential partners, and refining the product’s positioning in the competitive oncology landscape. The organization will be better equipped to secure funding, attract investments, and navigate the complex commercialization process to successfully introduce the therapy into the market.

Faculty Supervisor:

Mani Larijani

Student:

Partner:

I-INC Foundation for Business Development

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services

University:

Simon Fraser University

Program: